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Abstract: 
Background:  Diabetic foot ulcer is a major complication of diabetes with a high 
mortality and morbidity and now the most common cause of diabetic related 
hospitalization and disabling problem leading to amputation of the leg. Objectives: This 
study aimed to study effective management and outcome of diabetic’s foot in Khartoum 
main hospitals. Patients and Methods: This was observational, prospective, cross 
sectional, hospital based study of 133 diabetic patients subjected to hospital 
management of diabetic foot in five main hospitals at Khartoum State in the period from 
November 2018 to November 2019.  
Results: Male to female ratio was 1.9: 1. The mean age of the patients was 53.6±14.0 
years, with mean duration of diabetes 11.6±8.3 years.   Surgical management performed 
for130 patients, 65 (50%) had major amputation, 46(35.4%) debridement and 
19(14.6%) minor amputation,    deaths rate were 18(13.5%) in our patients. There was 
significant association between complications of diabetes ketoacidosis and 
hypertension related to major amputation and death (P < 0.05).  
Conclusion: In patient with diabetic foot ulcer in main Khartoum hospitals associated 
with high rate of major amputation, mortality, long hospital stay and high cost. Diabetic 
limb ischemia was major risk factor for major limb amputation. There significant 
association between diabetic ketoacidosis and hypertension related to major amputation 
and death. 
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Introduction: 
Diabetes affects approximately 3.9% of urban population in Sudan. Diabetic patients 
comprise about 3.3% of the surgical load in Hospitals. It is well known that diabetes 
carries significant rate of morbidities and increases the cost of management both for the 
individual patients and the health authorities.  Foot complications, especially foot ulcer 
constitute a major public health problem for diabetic patient in sub-Saharan Africa, and 
are important causes for prolonged hospital admission, and more frequent precursor to 
amputation, and death of patients from this part of the continent. More than half of all 
limb amputations are carried out in patients with diabetes mellitus. Amputation is 
preceded by a foot ulcer progressing to deep gangrenous infection; most of these ulcers 
are caused by minor trauma, frequently as a result of poorly fitting foot wear or 
inadequate foot care(i). 
The most common cause of hospitalization of diabetic patients is soft-tissue and bone 
infections involving the foot. Mild or superficial infections can be treated in the 
outpatient setting by oral antimicrobial agents and by avoidance of further irritation. 
Although many patients with severe infections are hospitalized and treated with 
intravenous antimicrobial therapy, the final outcome is frequently prolonged 
immobilization or loss of the limb. Diabetes mellitus is the leading cause of lower-
extremity amputation and accounts for about one-half of, all non-trauma- related 
amputations in the United States. The rate of lower-extremity amputation among 
diabetics is 17-40 times greater than that among non diabetics. Reported risk factors for 
lower-extremity amputation include non-healing ulcers, infection, advanced age, male 
sex, black race, and a history of smoking. Additional risk factors of amputation for 
patients with diabetic foot infection such as insufficient lower-extremity circulation, 
decreased ankle-arm blood pressure index, low levels of high- density lipoprotein sub 
fraction, and lack of previous education on outpatient care for diabetes(ii). 
Appropriate antibiotic therapy of a diabetic foot infection usually requires culturing the 
wound and performing sensitivity testing on isolated pathogens. The accuracy of a 
wound culture depends on obtaining an appropriate specimen. This requires careful 
attention to sterile technique as well as selection of the optimal portion of the wound 
for sampling. Before collecting a culture specimen, the wound should be derided of all 
necrotic material and mechanically cleansed. Three methods commonly used for 
obtaining foot culture samples are swabbing, needle aspiration and wound biopsy. Deep 
tissue specimens generally are considered to provide the most reliable culture samples 
in diabetic foot ulcers. One study compared culture specimens obtained by methods 
that minimize the likelihood of contamination(iii). 
Diabetes remains a major cause of mortality and morbidity and is increasing in 
prevalence at an alarming rate. Chronic complications of diabetes, especially 
cardiovascular disease, result in hospitalization in many patients with diabetes. In 
addition, diabetic patients stay in the hospital on average 1 to 3 days longer than patients 
without diabetes. The exact prevalence of diabetes among hospitalized patients is not 
known. However, in the year 2000, 12.4% of hospital discharges in the United States 
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listed diabetes as a diagnosis. Among cardiac surgery patients, the prevalence of 
diabetes is as high as 29%. In a retrospective review of 2,030 consecutive hospital 
admissions, Umpires et al  found that 718 (38%) of the 1,886 patients who had blood 
glucose measurements recorded in their charts had hyperglycemia. Of the patients with 
hyperglycemia, 495 had a known history of diabetes, but the other 223 did not. Of 
interest is that the patients with newly diagnosed hyperglycemia were more likely to 
require admission to the intensive care unit, had longer hospital stays, and were less 
likely to be discharged straight home(iv). 
Patients with diabetes are particularly susceptible to foot infection primarily because of 
neuropathy, vascular insufﬁciency, and diminished neutrophil function. Peripheral 
neuropathy has a central role in the development of a foot infection and it occurs in 
about 30 to 50 percent of patients with diabetes. Patients with diabetes lose the 
protective sensations for temperature and pain, impairing awareness of trauma such as 
abrasions ,blistering, or penetrating foreign body. Motor neuropathy can result in foot 
deformities (e.g., claw toe) that contribute to local pressure from footwear, making skin 
ulceration even more likely. Once the skin is broken (typically on the plantar surface), 
the underlying tissues are exposed to colonization by pathogenic organisms. The 
resulting wound infection may begin superﬁcially, but with delay in treatment and 
impaired body defense mechanisms caused by neutrophil dysfunction and vascular 
insufficiency, it can spread to the contiguous subcutaneous tissues and to deep 
structures. Although most diabetic foot infections begin with an ulcer, localized 
cellulitis and necrotizing fasciitis can develop in the absence of an ulcer or traumatic 
injury(v). Diabetic septic foot is major leading cause of limb amputation and handicap 
worldwide.  Hospital management of DF needed mainly for short control of diabetes 
and infection and complicated cases. Our study performed to detect the outcome of 
hospital management of DF in Khartoum governmental hospitals in the period from 
November 2018 to November 2019.  
 
Patients and Methods: 
Observational prospective, cross sectional, hospital based study. The study was 
conducted at Khartoum main hospitals including Omdurman,  Khartoum North and 
Ibraheum Malik, Omdurman Military and Bashir university hospitals. The study was 
conducted during the period from November 2018 to November 2019. The study 
sample included 133 patients was received hospital treatment for diabetic foot. Data 
was collected using a questionnaire, about age, sex, diabetes information, hospital 
management of diabetic septic foot, complications, final outcome and cost of hospital 
stay. Data was analyzed by using a computer program Statistical Package for Social 
Sciences (SPSS). Chi squire test was used to test the relations between the variables 
with P value considered significant < 0.05. T test was used to calculate mean values of 
hospital stay, cost and age. Consent was obtained from the patients and ethical clearance 
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was obtained from ethical committee of Sudan Medical Specialization Board. 
 
Results: 
Male to female ratio was 1.9: 1.  Patients with Non-IDDM were 68(51.1%) and with 
IDDM were 65(48.9%). The mean age of the patients was 53.6±14.0 years.  The 
duration of hospital stay was 7-14 days in 58(43.6%) of the patients, less than 7 days 
43(32.4%), between 15 – 21 days 20(15%), between 22 – 28 days 6(4.5%) and more 
than 28 days 6(4.5%) (Figure 1). The mean duration of hospital stay was 11.3±10.1 
days. Regarding types of hospital management all of the patients received IV antibiotics 
and insulin injection and surgical management performed for 130(97.7%) of the 
patients (Table 1). The range of cost of hospital stay (whole duration) was 5000 – 10000 
SDG in 53(39.8%) of the patients, followed by 1000 – 5000 SDG 46(34.6%), 11000 – 
15000 SDG 15(11.3%), above 15000 SDG 15(11.3%) and less than 1000 SDG 4(3%) 
(Table 2). The mean value of cost of hospital stay for whole duration was 8257.3±944.8 
SDG. The mean values of cost in relation to final outcome came as follow: 8855.0, 
6242.7, 6798.2, 9577.0, 44110.0, and 11448.9 in healed patients, discharged on 
outpatient, minor amputation, major amputation, loss of follow up and death 
respectively (Table 3).  Significant association found between prescription of antibiotic 
without culture sensitivity and some poor outcome, which appeared in 38(56.7%) and 
13(19.4%) of the patients with major amputation and death cases respectively (P value 
= 0.01 < 0.05) (Table 4).  
  
Figure (1): Distribution of the patients with diabetic foot according to duration 
of hospital stay 
 
Table (1): Distribution of the patients with diabetic foot according to type of 
management received in the hospital   
 
Type of management  
Yes No 
N % N % 
IV antibiotics 133 100.0 0 0.0 
Insulin injection  133 100.0 0 0.0 
Surgical intervention 130 97.7 1 0.8 
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Table (2): Distribution of the patients with diabetic foot according to cost of 
hospital stay  
Cost per whole duration of hospital stay N % 
< 1000 SDG 4 3.0 
1000 - 5000 SDG 46 34.6 
5000 - 10000 SDG 53 39.8 
11000 - 15000 SDG 15 11.3 
> 15000 SDG 15 11.3 
Total 133 100.0 
 
Table (3): Distribution of the patients with diabetic foot according to mean cost of 
hospital stay in relation to final outcome  
Final outcome Mean ±SD 
Healing 8855.0 217.8 
Discharged on outpatient dressing 6242.7 674.1 
Minor amputation 6798.2 657.8 
Major amputation 9577.0 140.2 
Loss of follow up 4110.0 794.2 
Death 11448.9 6456.2 
 
Table (4): Distribution of the patients with diabetic foot according to performance 
of culture sensitivity in relation to amputation and death  
 
 
Amputation and death 
Antibiotics given according to CS 
Yes No 
N % N % 
Minor amputation 1 7.1 16 23.9 
Major amputation 8 57.1 38 56.7 
Death 5 35.7 13 19.4 
Total  14 100.0 67 100.0 
P value = 0.01 < 0.05 
DISCUSSION 
In this study 133 diabetic patients underwent management of diabetic foot at 5 main 
hospitals in Khartoum State participated to assess management and outcome of 
diabetic’s foot. Male to female ratio was 1.9: 1. The mean age of the patients was 
53.6±14.0 years, with mean duration of diabetes 11.6±8.3 years. This is similar to El 
Bushra(vi) studied the magnitude, presentations and outcomes of diabetic septic foot 
lesions in El Obeid, Western. There were 55 males and 26 females. The mean age was 
56.81 years ± SD 12. Also Fawzy et al( vii ) prospective study was conducted at 
researchers’ area “Northern area of Saudi Arabia” to determine the factors associated 
with diabetic foot (DF) among T2DM patients. Two hundred T2DM patients 
with/without DF (n = 100 for each group) were recruited. In total, the mean (SD) age 
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of participants was 56 (± 12.2) years and nearly 70% of the patients were females. 
Moreover, Pemaym and Naibaho(viii) in a study attempted to determine the disease 
burden in terms of clinical profile and outcome of diabetic foot ulcer (DFU) admissions 
at a tertiary care hospital in a developing country. Foot problems accounted for 16.2% 
of total diabetic admission (n = 1429). All patients had type 2 diabetes with no gender 
predominance. The mean age was 54.3 ± 8.6 years. 
In our study all of the patients received IV antibiotics injection including 
Samixon(Ceftriaxon), Flagyl(Metronidazole), Maxil, Fortum and Cefizox. In the 
majority of the patients 114(85.7%) the antibiotics were prescribed without culture 
sensitivity, this procedure done for 19(14.3%) of the patients. Similar to Wahab et al(ix) 
study in Jabir Abueliz Diabetic Center Khartoum, among diabetic patients with diabetic 
foot culture done for 302 out of 3620. All patients took antibiotics. Ceftriaxone and 
ciprofloxacin were the most used drugs. 
On the other hand, 130 patients underwent surgical management, of them 65(50%) 
underwent major amputation, 46(35.4%) debridement and 19(14.6%) minor 
amputation. This is the same as concluded by El Bushra[6] in El Obeid, Western Sudan 
reported 20 patients ended with major lower limb amputations (24.7%) and 23 others 
had minor toe amputations (28.4%).   
The study showed that the mean duration of hospital stay was 11.3±10.1 days and the 
mean cost of hospital stays for whole duration was 8257.3±944.8 SDG. On the other 
hand mean values in relation to final outcome came as follow: 8855.0, 6242.7, 6798.2, 
9577.0, 44110.0, and 11448.9 in healed patients, discharged on outpatient, minor 
amputation, major amputation, loss of follow up and death respectively. This is 
comparable to SaadEldein,  et al(x) study among patients with diabetic foot admitted to 
Wad Medani Teaching Hospital reported that the mean hospital stay was 13.3±15.6 
days, after three months of follow up (32.1%) were cured without amputation, (1.3%) 
had recurrence and (10.7%) had persistent ulcers. Muhammad et al(xi)estimated cost of 
illness among patients with diabetic foot ulcer in northwestern Nigeria. Majority of the 
patients were males with the mean age of 59.3±15.1 yrs. About 60% of the patients earn 
less than $100 monthly. The total cost of illness of diabetic foot ulcer was estimated at 
$140,735.56 (median=$1381.55[IQR 1002.42-]). Direct cost of illness was 
$107,797.06 (median=$1023.27[IQR 773.93–1568]), while the indirect cost was 
$32,938.49 (median=$209.90[IQR 128.74–357.08]). Out of pocket payment accounted 
for 90% of the payment. Cavanagh et al(xii) study in 5 different counties reported that 
there were marked differences in the treatment plans between countries based on the 
availability of resources and the realities of local conditions. The costs of treatment for 
case 1 ranged from Int$102 to Int$3959 in Tanzania and in the United States, 
respectively. The cost for case 2 ranged from Int$3060 to Int$188 645 in Tanzania and 
in the United States, respectively. The cost burden to the patient varied from the 
equivalent of 6 days of average income in the United States for case 1 to 5.7 years of 
average annual income for case 2 in India. Although these findings do not take cost-
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effectiveness into account, they highlight the dramatic economic burden of a DFU for 
patients in some countries. 
Regarding the final outcome in terms of major amputation and death, 46(34.6%) with 
major amputation and deaths were 18(13.5%). These in turn significantly associated 
with complications of diabetes ketoacidosis and co-morbidity of hypertension (P value 
< 0.05). This is similar to Adam et al(xiii) reported that major lower limb amputation and 
mortality were 19.2%, and 6.7% respectively. Pemaym and Naibaho(xiv) found that a 
total of 98 (36.3%) lower extremity amputations (LEAs) at various level of the foot 
were carried out, including major LEA in 24 patients and multiple amputations in seven 
patients. Mortality rate due to DFU reached 10.7%.  
 
 
 
Conclusion: 
In patient with diabetic foot ulcer in main Khartoum hospitals associated with high rate 
of major amputation, mortality, long hospital stay and high cost .diabetic limb ischemia 
was major risk factor for major limb amputation. There was significant association 
between diabetic ketoacidosis and hypertension related to major amputation and death. 
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